Showing results (181-190 of 274) with videos related to

Sort By:
Pageof 28
Diagnostics (Basel, Switzerland)|October 27, 2022
Pulmonary Hypertension Associated Genetic Variants in Sarcoidosis Associated Pulmonary HypertensionKarlijn Groen, Marloes P Huitema, Joanne J van der Vis, et al.
Therapeutics and Clinical Risk Management|November 18, 2016
Management of extrapulmonary sarcoidosis: challenges and solutionsKhalid Al-Kofahi, Peter Korsten, Christian Ascoli, et al.
Chest|August 7, 2021
Riociguat for Sarcoidosis-Associated Pulmonary Hypertension: Results of a 1-Year Double-Blind, Placebo-Controlled TrialRobert P Baughman, Oksana A Shlobin, Rohit Gupta, et al.
Frontiers in Medicine|May 17, 2021
COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and OpportunitiesMichael Manansala, Amit Chopra, Robert P Baughman, et al.
ERJ Open Research|December 28, 2018
Sarcoidosis: patient treatment prioritiesRobert P Baughman, Rita Barriuso, Kelli Beyer, et al.
Seminars in Respiratory and Critical Care Medicine|July 29, 2010
Rheumatologic manifestations of sarcoidosisNadera J Sweiss, Karen Patterson, Ray Sawaqed, et al.
Contemporary Clinical Trials|September 12, 2025
Design of RESOLVE Lung, a multinational Phase 2, randomized, placebo-controlled trial of the anti-GM-CSF monoclonal antibody namilumab in patients with chronic pulmonary sarcoidosisBernt van den Blink, Chantal M Petit, Hayes M Dansky, et al.
Mediators of Inflammation|August 25, 2015
Binding of CXCL8/IL-8 to Mycobacterium tuberculosis Modulates the Innate Immune ResponseAgnieszka Krupa, Marek Fol, Bozena R Dziadek, et al.
Chest|March 30, 2013
Methotrexate vs azathioprine in second-line therapy of sarcoidosisAdriane D M Vorselaars, Wim A Wuyts, Veronique M M Vorselaars, et al.
Medicine|November 26, 2019
Cardiac sarcoidosis: worse pulmonary function due to left ventricular ejection fraction?: A case-control studyMagdalena M Martusewicz-Boros, Piotr W Boros, Elżbieta Wiatr, et al.
Pageof 28